Gene amplification in multidrug-resistant cells: Molecular and karyotypic events
โ Scribed by Andrey Gudkov; Boris Kopnin
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 659 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0265-9247
No coin nor oath required. For personal study only.
โฆ Synopsis
Multidrug resistance (MDR) is developed in a population of somatic mammalian cells in vivo or in vitro when they are selected for resistance to each of a large group of drugs (colchicine, adriamycin, actinomycin D , etc.). It isproduced by the amplification of some unknown gene@) whose praduct(s) evidently change@) rhe plasma membrane permeability of a cell to a selective agent and to other unrelated compounds. A large spec$c genomic region (150-250 kbp) undergoes amplification in MDR cells selected for the resistance to diflerent drugs. Amplijied DNA is locatedin homogeneously staining regions of chromosomes, double minute chromosomes and small chromatin bodies
episome-like structures that replicate out of the S-phase of a cell cycle. The selection of MDR cell variants is accompanied by regular karyotypic evolution specijic for this type of drug resistance.
๐ SIMILAR VOLUMES
The molecular basis for increased metallothionein concentrations in copperresistant hepatoma cells was examined. The copper-resistant cell line HAC, , , , which is maintained in 600 k m copper, had increased steady-state mRNA levels for both the metallothionein-1 (MT-1) and the metallothionein-2 (MT
## Abstract Gene amplification and copy number changes play a pivotal role in malignant transformation and progression of human tumor cells by mediating the activation of genes and oncogenes, which are involved in many different cellular processes including development of drug resistance. Since dox
Multidrug resistance-associated protein-1 (MRP1) is an integral membrane efflux protein that is implicated in multidrug resistance in cancer, but it is also expressed in normal tissues. The objective of this study was to determine the expression, localization and functional activity of MRP1 in prima
Using a DNA probe of mdrl and an anti-P-glycoprotein monoclonal antibody (MRK16), the authors investigated 19 cases of adult acute leukemia patients (one M1, six M2, three M3, one M4, three M5, two L1, and three L2), comparing leukemia cells at the initial presentation (I) with those at the relapsed